Mode
Text Size
Log in / Sign up

6-week multimodal exercise training feasible for frail people with multiple sclerosis in pilot RCTExercise Helps Frail MS Patients Feel Better

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider this pilot exercise intervention feasible for frail MS patients, but evidence is preliminary for clinical adoption.

This pilot randomized controlled trial evaluated the feasibility of a 6-week multimodal exercise training program in 16 frail people with multiple sclerosis. Participants were assigned to either the intervention (virtual reality treadmill training plus resistance training) or a waitlist control group. The primary outcome was feasibility, including recruitment, retention, adherence, safety, and user engagement.

Between-group differences in change from baseline to 6 weeks were reported for several secondary outcomes. For the Evaluative Frailty Index for Physical Activity, the difference was -0.07 (95% CI: -0.14, -0.00). The MSQoL-54 mental health score improved by +21.24 (95% CI: 7.32, 35.16), and the physical health score improved by +19.26 (95% CI: 5.61, 32.91). The Modified Fatigue Impact Scale showed a reduction of -11.46 (95% CI: -18.34, -5.13), and the Physiological Profile Assessment showed a change of -0.09 (95% CI: -1.19, 1.01).

Safety was good: no adverse events were recorded, and no training-related pain was reported. Two participants discontinued (1 in each group). The study was small and pilot in nature, with no reported limitations or funding details.

These findings support the viability of this exercise program for future larger-scale trials in frail people with multiple sclerosis, but the evidence is preliminary and not definitive for clinical practice.

Imagine waking up and feeling too tired to get out of bed. For many people with multiple sclerosis (MS), this is not just a bad day; it is their normal life. Frailty makes them feel weak, slow, and easily overwhelmed by daily tasks.

Frailty is becoming a big problem for people living with MS. It is linked to worse health outcomes and a lower quality of life. Currently, there are very few specific treatments to fix this weakness. Most doctors focus on managing the disease itself, but they struggle to help with the physical decline.

Patients often feel stuck. They want to move more, but their bodies say no. Existing exercise advice is often too vague or too hard for someone who is already struggling. This leaves a gap in care that many families need filled.

The surprising shift

For a long time, experts thought exercise might be too risky for very frail patients. They worried that pushing too hard could cause injury or burnout. But here is the twist: a new approach changes that thinking.

Instead of just walking or lifting weights alone, researchers tried something different. They combined resistance training with virtual reality treadmill walking. This mix might be the key to getting people moving safely.

What scientists didn't expect

Think of your brain and body like a busy intersection. When you walk normally, your brain sends signals to your legs. But in MS, those signals get jammed up.

This new method acts like a traffic cop. The virtual reality game gives your brain a fun reason to move. At the same time, the resistance training builds muscle strength. Together, they clear the traffic jam and help signals flow better.

Sixteen people with MS joined this pilot study. They were all considered frail based on medical scores. Half of them joined a six-week program. The other half waited to see what happened.

The active group used a special treadmill connected to a virtual world. They also did strength exercises. The waiting group did nothing special during this time. Researchers watched closely to see if people could stick with the plan.

The results were very encouraging. Almost everyone who started the program finished it. Only two people dropped out, which is a very low number.

Participants completed over 97% of their planned workouts. They did not feel pain or get hurt during the sessions. More importantly, they felt better mentally and physically. Their scores for mental health and physical health improved significantly.

This doesn't mean this treatment is available yet.

Fatigue scores also dropped by a large amount. People reported feeling less tired and having more energy for their daily lives. They loved the program and said they would recommend it to others.

The catch

But there is a catch. This was a small study with only sixteen people. It was a pilot trial, which means it is the first step before a big official test. We do not know if this works for everyone or in all hospitals yet.

Doctors see this as a promising start. It fits into the bigger picture of keeping people active safely. Experts say that combining fun technology with physical exercise is a smart way to build strength without causing stress.

If you or a loved one has MS and feels frail, talk to your doctor about exercise. Ask if a gentle, fun program is right for you. Do not try to start intense workouts on your own. Safety comes first.

This study has limits. It was small and short. It only looked at feasibility, which means it proved the idea works. It did not prove that it will cure frailty or stop the disease. Larger studies are needed to confirm these benefits.

Researchers plan to run bigger trials soon. They want to see if this method helps more people over a longer time. If the results hold up, this could become a standard part of MS care. Until then, it remains an exciting option to discuss with your healthcare team.

Study Details

Study typeRct
Sample sizen = 33
EvidenceLevel 2
Follow-up92.4 mo
PublishedJan 2026
View Original Abstract ↓
BACKGROUND: Frailty is increasingly recognized as a prevalent and debilitating condition in people with multiple sclerosis (MS) and is linked to poorer health outcomes. However, targeted interventions remain limited. The objective of this study was to examine the feasibility of a multimodal exercise training (MET) program to reduce frailty in frail people with MS. MATERIALS AND METHODS: Sixteen frail people with MS (age = 55.0 ± 7.7 years, 81.3% female, Fried frailty score ≥3) participated in this pilot randomized controlled trial. Participants were randomly assigned to a 6-week MET program consisting of virtual reality treadmill training + resistance training (n = 8) or to a waitlist control group (n = 8). Feasibility outcomes included recruitment, retention, and adherence rates as well as safety and user engagement throughout the study (Study Participant Feedback Questionnaire-SPFQ). Exploratory outcomes were collected at baseline and 6 weeks and included the Evaluative Frailty Index for Physical Activity (EFIP), the 54-item MS Quality of Life questionnaire (MSQoL-54), the Modified Fatigue Impact Scale (MFIS), and the Physiological Profile Assessment (PPA). RESULTS: Fourteen participants, eight in the intervention group and six in the control group, completed the study. The recruitment rate was 0.33 participants/week, retention was 87.5%, and adherence was high, with participants completing 97.2% of planned training sessions. No adverse events or training-related pain were recorded. The data collection procedures were successfully implemented with complete outcome data. Participants agreed or strongly agreed with 95.7% of applicable SPFQ items, indicating high levels of engagement and satisfaction with the trial. Between-group differences in baseline to 6-week change were: EFIP -0.07 (95% CI: -0.14, -0.00); MSQoL-54 mental health +21.24 (95% CI: 7.32, 35.16); MSQoL-54 physical health +19.26 (95% CI: 5.61, 32.91); MFIS -11.46 (95% CI: -18.34, -5.13); and PPA -0.09 (95% CI: -1.19, 1.01). CONCLUSION: The MET program was safe, feasible, and well-received by frail people with MS. These findings support the viability of MET for future larger-scale trials targeting frailty reduction in this population. TRIAL REGISTRATION: ClinicalTrials.gov NCT06042244.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.